Mari Thomas Selected Research

Immunoglobulin G (IgG)

1/2023	Acquired Glanzmann's thrombasthenia with IgG and IgA against activated αIIb β3.
1/2019	Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mari Thomas Research Topics

Disease

17	Thrombotic Thrombocytopenic Purpura 03/2024 - 07/2014
3	Thrombotic Microangiopathies 01/2019 - 01/2017
2	Thrombocytopenia (Thrombopenia) 01/2023 - 09/2020
2	Serum Sickness 01/2022 - 01/2019
2	Neoplasms (Cancer) 11/2021 - 01/2021
2	Pulmonary Embolism 11/2021 - 01/2020
1	Pre-Eclampsia (Preeclampsia) 11/2023
1	Thrombasthenia (Glanzmann Thrombasthenia) 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Venous Thromboembolism 11/2021
1	COVID-19 02/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2020
1	Hemorrhage 09/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	POEMS Syndrome (Syndrome, POEMS) 01/2020
1	Abdominal Pain (Pain, Abdominal) 11/2019
1	Lethargy 11/2019
1	Stroke (Strokes) 11/2019
1	Headache (Headaches) 11/2019
1	Hepatitis C 01/2017
1	Thrombosis (Thrombus) 08/2016

Drug/Important Bio-Agent (IBA)

6	thiamine triphosphorate (TTP)IBA 03/2024 - 07/2014
5	Rituximab (Mabthera)FDA Link 01/2022 - 06/2017
4	ThrombospondinsIBA 01/2023 - 07/2018
4	Metalloproteases (Metalloproteinases)IBA 01/2023 - 07/2018
4	DisintegrinsIBA 01/2023 - 07/2018
4	AntibodiesIBA 01/2019 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2019
2	AutoantibodiesIBA 01/2019 - 12/2014
1	von Willebrand FactorIBA 11/2023
1	Tyrosine (L-Tyrosine)FDA Link 11/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	caplacizumabIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	ofatumumab FDA Link 01/2022
1	obinutuzumabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	AnticoagulantsIBA 01/2021
1	Factor Xa (Coagulation Factor Xa)IBA 01/2021
1	Inosine Triphosphate (ITP)IBA 09/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	vinyltriethoxysilane (VTES)IBA 01/2020
1	Biosimilar PharmaceuticalsIBA 01/2019
1	EnzymesIBA 01/2019
1	SolventsIBA 01/2017
1	Detergents (Detergent)IBA 01/2017
1	AntigensIBA 01/2017
1	PrionsIBA 01/2017
1	EpitopesIBA 12/2014

Therapy/Procedure

3	Therapeutics 01/2023 - 11/2019
2	Aftercare (After-Treatment) 01/2023 - 01/2017
2	Plasma Exchange 02/2021 - 01/2017
1	Cytoreduction Surgical Procedures 11/2021
1	Treatment Delay 11/2021
1	Vena Cava Filters (Inferior Vena Cava Filter) 11/2021
1	Neoadjuvant Therapy 11/2021
1	Catheters 01/2020
1	Stem Cell Transplantation 01/2020